CNS Drug Development: Lessons Learned Part 3: Psychiatric and Central Nervous System Drugs Developed Over the Last Decade—Implications for the Field-Reference-Cited by-同舟云学术

CNS Drug Development: Lessons Learned Part 3: Psychiatric and Central Nervous System Drugs Developed Over the Last Decade—Implications for the Field

Published:2017-09 Issue:5 Volume:23 Page:352-360
ISSN:1527-4160
Container-title:Journal of Psychiatric Practice
language:en
Short-container-title:

Author:

PRESKORN SHELDON H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Psychiatry and Mental health

Reference14 articles.

1. Psychiatry: into the 21st century;Preskorn;J Psychiatr Pract,1995

2. Advances in psychiatry through genes, molecules and images;Preskorn;J Psychiatr Pract,1995

3. The stages of drug development and the human genome project: drug discovery;Preskorn;J Psychiatr Pract,2000

4. Targeted opioid receptor antagonists in the treatment of alcohol use disorders;Niciu;CNS Drugs,2013

5. Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception;Codd;J Pharmacol Exp Ther,1995

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reverse Engineering Drugs: Lorcaserin as an Example;Advances in Neurobiology;2023

2. Discovery of New Transmitter Systems and Hence New Drug Targets;Advances in Neurobiology;2023

3. Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development;Advances in Neurobiology;2023

4. QSAR model to predict K_p,uu,brain with a small dataset, incorporating predicted values of related parameter;SAR and QSAR in Environmental Research;2022-11-02

5. How an Understanding of the Function of the Locus Coeruleus Led to Use of Dexmedetomidine to Treat Agitation in Bipolar Disorder: Example of Rational Development of Psychiatric Medications;Journal of Psychiatric Practice;2022-05